Global Canine Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Canine Influenza Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Canine Influenza Vaccine industry chain, the market status of Vaccination Clinic (H3N2 Vaccine, H3N8 Vaccine), Pet Hospital (H3N2 Vaccine, H3N8 Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Canine Influenza Vaccine.

Regionally, the report analyzes the Canine Influenza Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Canine Influenza Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Canine Influenza Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Canine Influenza Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., H3N2 Vaccine, H3N8 Vaccine).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Canine Influenza Vaccine market.

Regional Analysis: The report involves examining the Canine Influenza Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Canine Influenza Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Canine Influenza Vaccine:
Company Analysis: Report covers individual Canine Influenza Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Canine Influenza Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Vaccination Clinic, Pet Hospital).

Technology Analysis: Report covers specific technologies relevant to Canine Influenza Vaccine. It assesses the current state, advancements, and potential future developments in Canine Influenza Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Canine Influenza Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Canine Influenza Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    H3N2 Vaccine
    H3N8 Vaccine

Market segment by Application
    Vaccination Clinic
    Pet Hospital
    Others

Major players covered
    Bharat Biotech
    GSK
    Novartis
    Merck Animal Health
    Roche
    Zoetis
    CSL Limited
    CNBG
    LIAONING CHENGDA

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Canine Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Canine Influenza Vaccine, with price, sales, revenue and global market share of Canine Influenza Vaccine from 2019 to 2024.
Chapter 3, the Canine Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Canine Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Canine Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Canine Influenza Vaccine.
Chapter 14 and 15, to describe Canine Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Canine Influenza Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Canine Influenza Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 H3N2 Vaccine
        1.3.3 H3N8 Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Canine Influenza Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Vaccination Clinic
        1.4.3 Pet Hospital
        1.4.4 Others
    1.5 Global Canine Influenza Vaccine Market Size & Forecast
        1.5.1 Global Canine Influenza Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Canine Influenza Vaccine Sales Quantity (2019-2030)
        1.5.3 Global Canine Influenza Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Bharat Biotech
        2.1.1 Bharat Biotech Details
        2.1.2 Bharat Biotech Major Business
        2.1.3 Bharat Biotech Canine Influenza Vaccine Product and Services
        2.1.4 Bharat Biotech Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bharat Biotech Recent Developments/Updates
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Canine Influenza Vaccine Product and Services
        2.2.4 GSK Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 GSK Recent Developments/Updates
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Canine Influenza Vaccine Product and Services
        2.3.4 Novartis Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Novartis Recent Developments/Updates
    2.4 Merck Animal Health
        2.4.1 Merck Animal Health Details
        2.4.2 Merck Animal Health Major Business
        2.4.3 Merck Animal Health Canine Influenza Vaccine Product and Services
        2.4.4 Merck Animal Health Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Merck Animal Health Recent Developments/Updates
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche Canine Influenza Vaccine Product and Services
        2.5.4 Roche Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Roche Recent Developments/Updates
    2.6 Zoetis
        2.6.1 Zoetis Details
        2.6.2 Zoetis Major Business
        2.6.3 Zoetis Canine Influenza Vaccine Product and Services
        2.6.4 Zoetis Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Zoetis Recent Developments/Updates
    2.7 CSL Limited
        2.7.1 CSL Limited Details
        2.7.2 CSL Limited Major Business
        2.7.3 CSL Limited Canine Influenza Vaccine Product and Services
        2.7.4 CSL Limited Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 CSL Limited Recent Developments/Updates
    2.8 CNBG
        2.8.1 CNBG Details
        2.8.2 CNBG Major Business
        2.8.3 CNBG Canine Influenza Vaccine Product and Services
        2.8.4 CNBG Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 CNBG Recent Developments/Updates
    2.9 LIAONING CHENGDA
        2.9.1 LIAONING CHENGDA Details
        2.9.2 LIAONING CHENGDA Major Business
        2.9.3 LIAONING CHENGDA Canine Influenza Vaccine Product and Services
        2.9.4 LIAONING CHENGDA Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 LIAONING CHENGDA Recent Developments/Updates

3 Competitive Environment: Canine Influenza Vaccine by Manufacturer
    3.1 Global Canine Influenza Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Canine Influenza Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global Canine Influenza Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Canine Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Canine Influenza Vaccine Manufacturer Market Share in 2023
        3.4.2 Top 6 Canine Influenza Vaccine Manufacturer Market Share in 2023
    3.5 Canine Influenza Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Canine Influenza Vaccine Market: Region Footprint
        3.5.2 Canine Influenza Vaccine Market: Company Product Type Footprint
        3.5.3 Canine Influenza Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Canine Influenza Vaccine Market Size by Region
        4.1.1 Global Canine Influenza Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global Canine Influenza Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global Canine Influenza Vaccine Average Price by Region (2019-2030)
    4.2 North America Canine Influenza Vaccine Consumption Value (2019-2030)
    4.3 Europe Canine Influenza Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific Canine Influenza Vaccine Consumption Value (2019-2030)
    4.5 South America Canine Influenza Vaccine Consumption Value (2019-2030)
    4.6 Middle East and Africa Canine Influenza Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Canine Influenza Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global Canine Influenza Vaccine Consumption Value by Type (2019-2030)
    5.3 Global Canine Influenza Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Canine Influenza Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global Canine Influenza Vaccine Consumption Value by Application (2019-2030)
    6.3 Global Canine Influenza Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America Canine Influenza Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America Canine Influenza Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America Canine Influenza Vaccine Market Size by Country
        7.3.1 North America Canine Influenza Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America Canine Influenza Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Canine Influenza Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe Canine Influenza Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe Canine Influenza Vaccine Market Size by Country
        8.3.1 Europe Canine Influenza Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Canine Influenza Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Canine Influenza Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Canine Influenza Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Canine Influenza Vaccine Market Size by Region
        9.3.1 Asia-Pacific Canine Influenza Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Canine Influenza Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Canine Influenza Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America Canine Influenza Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America Canine Influenza Vaccine Market Size by Country
        10.3.1 South America Canine Influenza Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America Canine Influenza Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Canine Influenza Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Canine Influenza Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Canine Influenza Vaccine Market Size by Country
        11.3.1 Middle East & Africa Canine Influenza Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Canine Influenza Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Canine Influenza Vaccine Market Drivers
    12.2 Canine Influenza Vaccine Market Restraints
    12.3 Canine Influenza Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Canine Influenza Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Canine Influenza Vaccine
    13.3 Canine Influenza Vaccine Production Process
    13.4 Canine Influenza Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Canine Influenza Vaccine Typical Distributors
    14.3 Canine Influenza Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Canine Influenza Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Canine Influenza Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
    Table 4. Bharat Biotech Major Business
    Table 5. Bharat Biotech Canine Influenza Vaccine Product and Services
    Table 6. Bharat Biotech Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Bharat Biotech Recent Developments/Updates
    Table 8. GSK Basic Information, Manufacturing Base and Competitors
    Table 9. GSK Major Business
    Table 10. GSK Canine Influenza Vaccine Product and Services
    Table 11. GSK Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. GSK Recent Developments/Updates
    Table 13. Novartis Basic Information, Manufacturing Base and Competitors
    Table 14. Novartis Major Business
    Table 15. Novartis Canine Influenza Vaccine Product and Services
    Table 16. Novartis Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Novartis Recent Developments/Updates
    Table 18. Merck Animal Health Basic Information, Manufacturing Base and Competitors
    Table 19. Merck Animal Health Major Business
    Table 20. Merck Animal Health Canine Influenza Vaccine Product and Services
    Table 21. Merck Animal Health Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Merck Animal Health Recent Developments/Updates
    Table 23. Roche Basic Information, Manufacturing Base and Competitors
    Table 24. Roche Major Business
    Table 25. Roche Canine Influenza Vaccine Product and Services
    Table 26. Roche Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Roche Recent Developments/Updates
    Table 28. Zoetis Basic Information, Manufacturing Base and Competitors
    Table 29. Zoetis Major Business
    Table 30. Zoetis Canine Influenza Vaccine Product and Services
    Table 31. Zoetis Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Zoetis Recent Developments/Updates
    Table 33. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 34. CSL Limited Major Business
    Table 35. CSL Limited Canine Influenza Vaccine Product and Services
    Table 36. CSL Limited Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. CSL Limited Recent Developments/Updates
    Table 38. CNBG Basic Information, Manufacturing Base and Competitors
    Table 39. CNBG Major Business
    Table 40. CNBG Canine Influenza Vaccine Product and Services
    Table 41. CNBG Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. CNBG Recent Developments/Updates
    Table 43. LIAONING CHENGDA Basic Information, Manufacturing Base and Competitors
    Table 44. LIAONING CHENGDA Major Business
    Table 45. LIAONING CHENGDA Canine Influenza Vaccine Product and Services
    Table 46. LIAONING CHENGDA Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. LIAONING CHENGDA Recent Developments/Updates
    Table 48. Global Canine Influenza Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
    Table 49. Global Canine Influenza Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 50. Global Canine Influenza Vaccine Average Price by Manufacturer (2019-2024) & (USD/Dose)
    Table 51. Market Position of Manufacturers in Canine Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 52. Head Office and Canine Influenza Vaccine Production Site of Key Manufacturer
    Table 53. Canine Influenza Vaccine Market: Company Product Type Footprint
    Table 54. Canine Influenza Vaccine Market: Company Product Application Footprint
    Table 55. Canine Influenza Vaccine New Market Entrants and Barriers to Market Entry
    Table 56. Canine Influenza Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Canine Influenza Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
    Table 58. Global Canine Influenza Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
    Table 59. Global Canine Influenza Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 60. Global Canine Influenza Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 61. Global Canine Influenza Vaccine Average Price by Region (2019-2024) & (USD/Dose)
    Table 62. Global Canine Influenza Vaccine Average Price by Region (2025-2030) & (USD/Dose)
    Table 63. Global Canine Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 64. Global Canine Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 65. Global Canine Influenza Vaccine Consumption Value by Type (2019-2024) & (USD Million)
    Table 66. Global Canine Influenza Vaccine Consumption Value by Type (2025-2030) & (USD Million)
    Table 67. Global Canine Influenza Vaccine Average Price by Type (2019-2024) & (USD/Dose)
    Table 68. Global Canine Influenza Vaccine Average Price by Type (2025-2030) & (USD/Dose)
    Table 69. Global Canine Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 70. Global Canine Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 71. Global Canine Influenza Vaccine Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. Global Canine Influenza Vaccine Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. Global Canine Influenza Vaccine Average Price by Application (2019-2024) & (USD/Dose)
    Table 74. Global Canine Influenza Vaccine Average Price by Application (2025-2030) & (USD/Dose)
    Table 75. North America Canine Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 76. North America Canine Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 77. North America Canine Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 78. North America Canine Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 79. North America Canine Influenza Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
    Table 80. North America Canine Influenza Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
    Table 81. North America Canine Influenza Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 82. North America Canine Influenza Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 83. Europe Canine Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 84. Europe Canine Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 85. Europe Canine Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 86. Europe Canine Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 87. Europe Canine Influenza Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
    Table 88. Europe Canine Influenza Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
    Table 89. Europe Canine Influenza Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 90. Europe Canine Influenza Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 91. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 92. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 93. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 94. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 95. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
    Table 96. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
    Table 97. Asia-Pacific Canine Influenza Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 98. Asia-Pacific Canine Influenza Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 99. South America Canine Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 100. South America Canine Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 101. South America Canine Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 102. South America Canine Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 103. South America Canine Influenza Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
    Table 104. South America Canine Influenza Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
    Table 105. South America Canine Influenza Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 106. South America Canine Influenza Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 107. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 108. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 109. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 110. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 111. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
    Table 112. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
    Table 113. Middle East & Africa Canine Influenza Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Canine Influenza Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 115. Canine Influenza Vaccine Raw Material
    Table 116. Key Manufacturers of Canine Influenza Vaccine Raw Materials
    Table 117. Canine Influenza Vaccine Typical Distributors
    Table 118. Canine Influenza Vaccine Typical Customers
List of Figures
    Figure 1. Canine Influenza Vaccine Picture
    Figure 2. Global Canine Influenza Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Canine Influenza Vaccine Consumption Value Market Share by Type in 2023
    Figure 4. H3N2 Vaccine Examples
    Figure 5. H3N8 Vaccine Examples
    Figure 6. Global Canine Influenza Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Canine Influenza Vaccine Consumption Value Market Share by Application in 2023
    Figure 8. Vaccination Clinic Examples
    Figure 9. Pet Hospital Examples
    Figure 10. Others Examples
    Figure 11. Global Canine Influenza Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Canine Influenza Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Canine Influenza Vaccine Sales Quantity (2019-2030) & (K Doses)
    Figure 14. Global Canine Influenza Vaccine Average Price (2019-2030) & (USD/Dose)
    Figure 15. Global Canine Influenza Vaccine Sales Quantity Market Share by Manufacturer in 2023
    Figure 16. Global Canine Influenza Vaccine Consumption Value Market Share by Manufacturer in 2023
    Figure 17. Producer Shipments of Canine Influenza Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 18. Top 3 Canine Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Top 6 Canine Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Global Canine Influenza Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 21. Global Canine Influenza Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 22. North America Canine Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 23. Europe Canine Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 24. Asia-Pacific Canine Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 25. South America Canine Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 26. Middle East & Africa Canine Influenza Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 27. Global Canine Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 28. Global Canine Influenza Vaccine Consumption Value Market Share by Type (2019-2030)
    Figure 29. Global Canine Influenza Vaccine Average Price by Type (2019-2030) & (USD/Dose)
    Figure 30. Global Canine Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 31. Global Canine Influenza Vaccine Consumption Value Market Share by Application (2019-2030)
    Figure 32. Global Canine Influenza Vaccine Average Price by Application (2019-2030) & (USD/Dose)
    Figure 33. North America Canine Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 34. North America Canine Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 35. North America Canine Influenza Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 36. North America Canine Influenza Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 37. United States Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Canada Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Mexico Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Europe Canine Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 41. Europe Canine Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 42. Europe Canine Influenza Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 43. Europe Canine Influenza Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 44. Germany Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. France Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. United Kingdom Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Russia Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Italy Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Asia-Pacific Canine Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 50. Asia-Pacific Canine Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 51. Asia-Pacific Canine Influenza Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 52. Asia-Pacific Canine Influenza Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 53. China Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Japan Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Korea Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. India Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Southeast Asia Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Australia Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. South America Canine Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 60. South America Canine Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 61. South America Canine Influenza Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 62. South America Canine Influenza Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 63. Brazil Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Argentina Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Middle East & Africa Canine Influenza Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 66. Middle East & Africa Canine Influenza Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 67. Middle East & Africa Canine Influenza Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 68. Middle East & Africa Canine Influenza Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 69. Turkey Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Egypt Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Saudi Arabia Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. South Africa Canine Influenza Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Canine Influenza Vaccine Market Drivers
    Figure 74. Canine Influenza Vaccine Market Restraints
    Figure 75. Canine Influenza Vaccine Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Canine Influenza Vaccine in 2023
    Figure 78. Manufacturing Process Analysis of Canine Influenza Vaccine
    Figure 79. Canine Influenza Vaccine Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Companies Mentioned

Bharat Biotech
GSK
Novartis
Merck Animal Health
Roche
Zoetis
CSL Limited
CNBG
LIAONING CHENGDA